BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20856243)

  • 1. Understanding forgiveness: minding and mining the gaps between pharmacokinetics and therapeutics.
    Osterberg LG; Urquhart J; Blaschke TF
    Clin Pharmacol Ther; 2010 Oct; 88(4):457-9. PubMed ID: 20856243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient adherence to prescribed antimicrobial drug dosing regimens.
    Vrijens B; Urquhart J
    J Antimicrob Chemother; 2005 May; 55(5):616-27. PubMed ID: 15772145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose combinations improve medication compliance: a meta-analysis.
    Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
    Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 5. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial.
    Tabbutt S; Nicolson SC; Adamson PC; Zhang X; Hoffman ML; Wells W; Backer CL; McGowan FX; Tweddell JS; Bokesch P; Schreiner M
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):321-8. PubMed ID: 18692637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.
    Düsing R; Handrock R; Klebs S; Tousset E; Vrijens B
    J Hypertens; 2009 Apr; 27(4):894-901. PubMed ID: 19300114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronopharmacological aspects of PK/PD modelling.
    Lemmer B
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):458-64. PubMed ID: 9352396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral drug dosing errors in HIV-infected patients undergoing hemodialysis.
    Tourret J; Tostivint I; Tézenas Du Montcel S; Karie S; Launay-Vacher V; Vigneau C; Bessette C; Deray G; Bagnis CI
    Clin Infect Dis; 2007 Sep; 45(6):779-84. PubMed ID: 17712764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Now or never: optimal antihypertensive therapy in the elderly.
    Prisant LM
    Prev Cardiol; 2008; 11(4):201-9. PubMed ID: 19476572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structured treatment interruptions--new findings.
    Benson CA
    Top HIV Med; 2006; 14(3):107-11. PubMed ID: 16946455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nebivolol: in the treatment of hypertension in the US.
    Baldwin CM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(4):253-60. PubMed ID: 19655820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hypertension in a clinical trial. Depot alpha 1 blocker simplifies dosing].
    Sauerbrey-Wullkopf N; Leverkus F
    MMW Fortschr Med; 2003 Nov; 145(47):54. PubMed ID: 14725035
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug therapy of hypertension: in search of an optimal regimen.
    Thatte U
    J Assoc Physicians India; 1999 Feb; 47(2):169-72. PubMed ID: 10999081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotensin 1-antagonists: primary therapeutic option in arterial hypertension, too].
    Traut
    Dtsch Med Wochenschr; 2003 Jan; 128(4):161; discussion 161-2. PubMed ID: 12589590
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlipidemia of diuretic therapy.
    Ames R
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.